Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04197765 · ClinicalTrials.gov registry record · NA

acTBS Treatment for Inpatient Subjects With Suicidality

A NA study of Suicidality, sponsored by University of California, Los Angeles.

Active
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT04197765 is a NA study of Suicidality that is active but no longer recruiting, run by University of California, Los Angeles. The registered enrollment target is 40 participants, below the 395-participant average among 4 other Suicidality trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04197765, a NA study of Suicidality, is active but no longer recruiting, sponsored by University of California, Los Angeles.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This is a pilot study to analyze the benefit of accelerated continuous Transcranial magnetic stimulation for inpatient subjects suffering with suicidal ideation. This study will enroll 40 inpatient subjects recruited from the Resnick Neuropsychiatric hospital. Subjects will be blinded and randomized to active or sham TMS treatment and will receive up to 5 assigned treatments per day. Subjects will also be asked to complete mood surveys throughout their participation. Participation in this study will last 7-10 days depending on scheduling.

Conditions Studied

Interventions

  • DEVICE Sham Comparator
  • DEVICE accelerated Thetaburst stimulation

Study Locations (1)

California

  • Resnick Neuropsychiatric Hospital - Los Angeles

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2020-01-01
Est. Completion 2029-01-01
Phase NA

What the Registry Record Tells You About NCT04197765

The ClinicalTrials.gov registry entry for NCT04197765 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 395-participant average among 4 other Suicidality trials with a reported enrollment target (90% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Suicidality appearing as the primary indexed condition, and to 2 interventions - of which Sham Comparator is the first listed.

NCT04197765 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04197765 about?

NCT04197765 is a clinical study titled "acTBS Treatment for Inpatient Subjects With Suicidality". This is a pilot study to analyze the benefit of accelerated continuous Transcranial magnetic stimulation for inpatient subjects suffering with suicidal ideation. This study will enroll 40 inpatient subjects recruited from the Resnick Neuropsychiatric hospital. Subjects will be blinded and randomized...

What is the current status of trial NCT04197765?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2020-01-01. Estimated completion is 2029-01-01.

What conditions does trial NCT04197765 study?

This clinical trial studies the following conditions: Suicidality.

What interventions are being tested in trial NCT04197765?

The interventions under investigation include: Sham Comparator (DEVICE), accelerated Thetaburst stimulation (DEVICE).

Who is sponsoring clinical trial NCT04197765?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04197765 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicidality

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.